Literature DB >> 10823880

Design and intracellular activity of a human single-chain antibody to human immunodeficiency virus type 1 conserved gp41 epitope.

I Legastelois1, C Desgranges.   

Abstract

A human lymphoid cell line (F172-D8) excreting a human immunodeficiency virus type 1 (HIV-1) anti-gp41 monoclonal antibody was used to construct a plasmid containing the cDNA of the single-chain variable fragment (scFvD8) corresponding to this antibody. A stable human osteosarcoma cell line was obtained which expressed the scFvD8 protein in the cytoplasm. Whereas a cell line transfected with a control construct (pCI-neo) was readily and productively infected with laboratory (Ba-L) or primary HIV-1 isolates, the scFvD8 cell line did not support productive infection. Binding of the virus, internalization, and reverse transcription were not altered by scFvD8 expression, but gp160 expression was dramatically reduced. These data suggest that cytoplasmic expression of this artificial single-chain antibody can interfere with gp160 expression, thereby reducing the production of mature viral envelope proteins.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10823880      PMCID: PMC112060          DOI: 10.1128/jvi.74.12.5712-5715.2000

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  32 in total

1.  Packaging system for rapid production of murine leukemia virus vectors with variable tropism.

Authors:  N R Landau; D R Littman
Journal:  J Virol       Date:  1992-08       Impact factor: 5.103

2.  At least six nucleotides preceding the AUG initiator codon enhance translation in mammalian cells.

Authors:  M Kozak
Journal:  J Mol Biol       Date:  1987-08-20       Impact factor: 5.469

3.  Identification of three major phosphorylation sites within HIV-1 capsid. Role of phosphorylation during the early steps of infection.

Authors:  C Cartier; P Sivard; C Tranchat; D Decimo; C Desgranges; V Boyer
Journal:  J Biol Chem       Date:  1999-07-02       Impact factor: 5.157

4.  Variable region light chain genes encoding human antibodies to HIV-1.

Authors:  D David; M Zouali
Journal:  Mol Immunol       Date:  1995-01       Impact factor: 4.407

5.  Potent inhibition of human immunodeficiency virus type 1 replication by an intracellular anti-Rev single-chain antibody.

Authors:  L Duan; O Bagasra; M A Laughlin; J W Oakes; R J Pomerantz
Journal:  Proc Natl Acad Sci U S A       Date:  1994-05-24       Impact factor: 11.205

6.  Molecular and virological effects of intracellular anti-Rev single-chain variable fragments on the expression of various human immunodeficiency virus-1 strains.

Authors:  L Duan; H Zhang; J W Oakes; O Bagasra; R J Pomerantz
Journal:  Hum Gene Ther       Date:  1994-11       Impact factor: 5.695

7.  Design, intracellular expression, and activity of a human anti-human immunodeficiency virus type 1 gp120 single-chain antibody.

Authors:  W A Marasco; W A Haseltine; S Y Chen
Journal:  Proc Natl Acad Sci U S A       Date:  1993-08-15       Impact factor: 11.205

8.  Point mutations define a sequence flanking the AUG initiator codon that modulates translation by eukaryotic ribosomes.

Authors:  M Kozak
Journal:  Cell       Date:  1986-01-31       Impact factor: 41.582

9.  Combined intra- and extracellular immunization against human immunodeficiency virus type 1 infection with a human anti-gp120 antibody.

Authors:  S Y Chen; Y Khouri; J Bagley; W A Marasco
Journal:  Proc Natl Acad Sci U S A       Date:  1994-06-21       Impact factor: 11.205

10.  Intracellular antibodies as a new class of therapeutic molecules for gene therapy.

Authors:  S Y Chen; J Bagley; W A Marasco
Journal:  Hum Gene Ther       Date:  1994-05       Impact factor: 5.695

View more
  3 in total

Review 1.  The production and application of single-chain antibody fragments.

Authors:  D Blazek; V Celer
Journal:  Folia Microbiol (Praha)       Date:  2003       Impact factor: 2.099

2.  The selection of single-chain Fv antibody fragments specific to Bhlp 29.7 protein of Brachyspira hyodysenteriae.

Authors:  D Lobová; A Cízek; V Celer
Journal:  Folia Microbiol (Praha)       Date:  2009-04-18       Impact factor: 2.099

3.  Performance of Affinity-Improved DARPin Targeting HIV Capsid Domain in Interference of Viral Progeny Production.

Authors:  Kanokporn Sornsuwan; Weeraya Thongkhum; Thanathat Pamonsupornwichit; Tanawan Samleerat Carraway; Suthinee Soponpong; Supachai Sakkhachornphop; Chatchai Tayapiwatana; Umpa Yasamut
Journal:  Biomolecules       Date:  2021-09-30
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.